Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Assets    
Cash and cash equivalents $ 583,219 $ 286,250
Equity method investments 1,489,122 1,279,651
Loans 1,157,000  
Receivables held-for-sale 9,308 0
Real estate 357,633 359,176
Investments 17,876 55,377
Securitization assets 193,559 164,342
Other assets 127,575 100,364
Total Assets 3,935,532 3,459,067
Liabilities:    
Accounts payable, accrued expenses and other 75,813 59,944
Credit facilities 44,830 22,591
Non-recourse debt (secured by assets of $579 million and $723 million, respectively) 441,513 592,547
Senior unsecured notes 1,759,137 1,283,335
Convertible notes 291,690 290,501
Total Liabilities 2,612,983 2,248,918
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 78,419,939 and 76,457,415 shares issued and outstanding, respectively 784 765
Additional paid in capital 1,487,103 1,394,009
Accumulated deficit (193,530) (204,112)
Accumulated other comprehensive income (loss) 11,336 12,634
Non-controlling interest 16,856 6,853
Total Stockholders’ Equity 1,322,549 1,210,149
Total Liabilities and Stockholders’ Equity 3,935,532 3,459,067
Government receivables    
Assets    
Loans 130,685 248,455
Commercial receivables    
Assets    
Loans $ 1,026,555 $ 965,452